Following the line of data exposed in the previous subsection, we further evaluated the risk of contracting a urinary tract infection by determining the odds ratio for BMI, HbA1c, and the use of an SGLT2 inhibitor for the treatment of T2DM. This evidence concerns the gene SLC5A2 and type 2 diabetes mellitus.